- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ekso Bionics Holdings Inc (EKSO)
Ekso Bionics Holdings Inc stock price live, this page displays NASDAQ EKSO stock exchange data. View the EKSO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ekso Bionics Holdings Inc real time stock price chart below.
What Is the Ekso Bionics Holdings Inc Stock Price Today?
The Ekso Bionics Holdings Inc stock price today is 3.020.
What Is the Stock Symbol for Ekso Bionics Holdings Inc?
The stock symbol for Ekso Bionics Holdings Inc is ""EKSO.""
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKSO quote. (ISIN: US2826444000)
What Is the Ekso Bionics Holdings Inc Stock Price Today?
The Ekso Bionics Holdings Inc stock price today is 3.020.
What Is the Stock Symbol for Ekso Bionics Holdings Inc?
The stock symbol for Ekso Bionics Holdings Inc is ""EKSO.""
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKSO quote. (ISIN: US2826444000)
NASDAQ
Currency in USD
3.020
-0.120(-3.82%)
Real-time Data·
Fair Value
An estimate of a Ekso Bionics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.020
3.200
52 wk Range
2.730
19.200
EKSO Scorecard
Full Analysis
Quickly burning through cash
EKSO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Ekso Bionics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.0203.200
52 wk Range
2.73019.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EKSO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ekso Bionics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
34.750
Upside
+1,050.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Ekso Bionics Holdings Inc Company Profile
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Ekso Bionics Holdings Inc Earnings Call Summary for Q2/2025
- Ekso Bionics Q2 2025: EPS -$1.24 (1450% miss), revenue $2.06M (62.61% miss); stock fell 6.02%, recovered 7.05% after-hours
- Revenue down to $2.1M from $5M YoY; gross margin declined to 40% from 53%; net loss $2.7M
- Personal health segment expected to reach 25% of revenue in 2025, surpassing enterprise health by 2027
- CEO highlights AI's role in exoskeleton adoption; $2.4M in deferred enterprise sales pending
- Focus on expanding distribution, market access amid Medicare reimbursement changes in healthcare exoskeleton market
Last Updated: 28/07/2025, 22:14
Read Full TranscriptCompare EKSO to Peers and Sector
Metrics to compare | EKSO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEKSOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −7.6x | −0.5x | |
PEG Ratio | −0.02 | −0.24 | 0.00 | |
Price/Book | 0.7x | 2.8x | 2.6x | |
Price / LTM Sales | 0.5x | 5.4x | 3.3x | |
Upside (Analyst Target) | - | 59.5% | 43.4% | |
Fair Value Upside | Unlock | 7.2% | 7.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 34.750
(+1,050.66% Upside)
Earnings
Latest Release
Jul 28, 2025
EPS / Forecast
-1.24 / -0.08
Revenue / Forecast
2.06M / 5.51M
People Also Watch
FAQ
What Stock Exchange Does Ekso Bionics Trade On?
Ekso Bionics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Ekso Bionics?
The stock symbol for Ekso Bionics is "EKSO."
What Is the Ekso Bionics Market Cap?
As of today, Ekso Bionics market cap is 7.89M.
What Is Ekso Bionics's Earnings Per Share (TTM)?
The Ekso Bionics EPS (TTM) is -6.58.
From a Technical Analysis Perspective, Is EKSO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ekso Bionics Stock Split?
Ekso Bionics has split 4 times.
How Many Employees Does Ekso Bionics Have?
Ekso Bionics has 64 employees.
What is the current trading status of Ekso Bionics (EKSO)?
As of 08 Aug 2025, Ekso Bionics (EKSO) is trading at a price of 3.02, with a previous close of 3.14. The stock has fluctuated within a day range of 3.02 to 3.20, while its 52-week range spans from 2.73 to 19.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.